Back to top
more

Tenet Healthcare (THC)

(Real Time Quote from BATS)

$152.57 USD

152.57
556,792

-4.00 (-2.56%)

Updated Oct 7, 2024 02:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 252)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Debasmita Chatterjee headshot

4 Hospital Stocks Likely to Perform Well in 2H21

by Debasmita Chatterjee

Companies like UHS, ACHC, HCA and THC are well-poised to gain in the second half of 2021 as the hospital industry is expected to benefit from rebounding admissions and continuous M&A activities.

Why Is Tenet (THC) Down 0.8% Since Last Earnings Report?

by Zacks Equity Research

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain UnitedHealth Group (UNH) Stock

by Zacks Equity Research

UnitedHealth Group (UNH) gains from improved revenues stemming from strong segmental performances, expansion of service offerings and a strong cash balance.

Tenet Healthcare (THC) Announces Partial Redemption of Notes

by Zacks Equity Research

To boost financial flexibility, Tenet Healthcare (THC) announces partial redemption of senior secured notes to procure funds for paying down its future annual cash interest payments.

7 Reasons Why Select Medical (SEM) Stock Looks Attractive

by Zacks Equity Research

Select Medical (SEM) looks a profitable investment bet on the back of its top-line growth, backed by a solid financial position as well as acquisitions and joint ventures.

Tenet Healthcare (THC) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

MEDNAX's (MD) Earnings Beat Estimates in Q2, Improve Y/Y

by Zacks Equity Research

MEDNAX's (MD) Q2 results reflect solid volumes, partly offset by escalating expenses.

Magellan (MGLN) Q2 Earnings Decline Y/Y on High Expenses

by Zacks Equity Research

Magellan Health's (MGLN) second-quarter results dampened by escalating expenses, partly offset by growth in revenues and Healthcare segment.

Sapna Bagaria headshot

3 Hospital Stocks to Buy as the Top-Ranked Industry Rebounds

by Sapna Bagaria

Stocks in the hospital industry look set to grow on the back of higher patient admissions.

Ensign Group's (ENSG) Q2 Earnings In Line, Increase Y/Y

by Zacks Equity Research

Ensign Group's (ENSG) Q2 results gain from higher revenues, cost management, and better census and managed care skilled mix across its portfolio.

Molina Healthcare (MOH) Misses on Q2 Earnings, Hikes '21 View

by Zacks Equity Research

Molina Healthcare's (MOH) Q2 earnings suffer escalating expenses. However, the same was partly offset by improved revenues and better membership.

Humana's (HUM) Q2 Earnings Surpass Estimates, Tumble Y/Y

by Zacks Equity Research

Humana's (HUM) second-quarter earnings gain from higher revenues and strong performances by its Retail and Healthcare Services segments.

Encompass Health (EHC) Beats on Q2 Earnings, Hikes '21 View

by Zacks Equity Research

Encompass Health's (EHC) second-quarter results highlight growing revenues stemming from strong segmental performances, partly offset by elevated costs.

Centene's (CNC) Q2 Earnings Miss Estimates, Improve Y/Y

by Zacks Equity Research

Centene's (CNC) second-quarter earnings gain from better revenues and membership growth.

Tenet Healthcare (THC) Beats on Q2 Earnings, Ups '21 EPS View

by Zacks Equity Research

Tenet Healthcare's (THC) second-quarter results gain on the back of higher revenues, and well-performing Hospital, Ambulatory and Conifer segments, partly offset by escalating costs.

Tenet Healthcare (THC) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Tenet (THC) delivered earnings and revenue surprises of 45.87% and 3.80%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Tenet Healthcare (THC) Q2 Earnings Expected to Decline

by Zacks Equity Research

Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold on to Cigna (CI) Stock for Now

by Zacks Equity Research

Cigna (CI) is currently riding on solid top-line growth, expanding global presence and prudent capital deployment.

HCA Healthcare (HCA) Buys 80% Stake in BHS, Boosts Network

by Zacks Equity Research

HCA Healthcare (HCA) completes purchase of majority stake in Brookdale's BHS, which has added around 80 care sites to the former's portfolio enabling it to offer enhanced healthcare services.

Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare and Acadia Healthcare

by Zacks Equity Research

Zacks Industry Outlook Highlights: HCA Healthcare, Universal Health Services, Tenet Healthcare and Acadia Healthcare

Why Should You Hold HCA Healthcare (HCA) in Your Portfolio?

by Zacks Equity Research

Riding high on growth measures and a solid 2021 guidance, HCA Healthcare (HCA) holds enough potential to reap benefits for investors.

4 Hospital Stocks to Gain From Rising Admissions, Aging Demography

by Zacks Equity Research

Expanding patient volumes, use of telehealth services, cost-control efforts and an aging demography are tailwinds to the hospital industry.

Here's Why You Should Hold on to Universal Health (UHS) Now

by Zacks Equity Research

Banking on its Acute Care and Behavioral Health platforms along with a robust capital position, Universal Health (UHS) holds potential to reap benefits for investors.

    Tenet (THC) Hits Fresh High: Is There Still Room to Run?

    by Zacks Equity Research

    Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Tenet (THC) Is Attractively Priced Despite Fast-paced Momentum

    by Zacks Equity Research

    If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.